Intuitive Surgical Expands Equity Plan and Buyback Authorization

An announcement from Intuitive Surgical ( (ISRG) ) is now available.

Intuitive Surgical, Inc. reported that shareholders approved amendments to its 2010 Incentive Award Plan at the April 30, 2026 annual meeting, increasing shares reserved for equity awards from 120.35 million to 125.35 million, extending the plan’s term to January 29, 2036, and clarifying change-of-control treatment of awards. Shareholders also re-elected ten directors, endorsed executive compensation on an advisory basis, and ratified PricewaterhouseCoopers LLP as the independent auditor for 2026.

On the same date, the board expanded the company’s common stock repurchase authorization to a total of $5.0 billion, including remaining prior capacity, signaling continued capital return and confidence in the business while giving management flexibility on timing and method of buybacks. The enlarged equity plan and repurchase program together underscore Intuitive Surgical’s focus on long-term talent incentives and shareholder returns in a competitive medtech and capital equipment landscape.

The most recent analyst rating on (ISRG) stock is a Buy with a $651.00 price target. To see the full list of analyst forecasts on Intuitive Surgical stock, see the ISRG Stock Forecast page.

Spark’s Take on ISRG Stock

According to Spark, TipRanks’ AI Analyst, ISRG is a Outperform.

The score is driven primarily by strong financial fundamentals (high margins, robust free cash flow, minimal leverage) and an upbeat earnings update with raised procedure-growth guidance and strong procedure/system momentum. Offsetting this are a premium valuation (high P/E, no dividend yield provided) and a mixed technical picture with negative MACD and price still below longer-term moving averages, plus noted regional and cost headwinds from the call.

To see Spark’s full report on ISRG stock, click here.

More about Intuitive Surgical

Intuitive Surgical, Inc. operates in the medical technology industry, specializing in robotic-assisted, minimally invasive surgery systems and related instruments and services. Its flagship da Vinci surgical systems are used by hospitals and surgeons worldwide, positioning the company as a leader in surgical robotics with a strong presence in advanced healthcare and hospital capital equipment markets.

Average Trading Volume: 1,916,911

Technical Sentiment Signal: Hold

Current Market Cap: $162.1B

For an in-depth examination of ISRG stock, go to TipRanks’ Overview page.